NEOGEN CORP

NEOG · XNAS

CIK 711377fmd_09T7YGR19CVSWMNKANR735X9GDManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Jun 01, 2009 to Aug 31, 2026, 66 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.